NIH NIA Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)
NIH NIMH Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R61/R33 Clinical Trial Required)
NIH NIMH Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R33- Clinical Trial Required)
Alzheimer's Drug Discovery Foundation (ADDF) & Association for Frontotemporal Degeneration (AFTD) Accelerating Drug Discovery for Frontotemporal Degeneration
NIH NIMH NEI NIA NIAAA NIDCD NIDA NINDS BRAIN Initiative: Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain (R01 Clinical Trial Not Allowed)
NIH NIMH NEI NIA NIAAA NIDCD NIDA NINDS BRAIN Initiative: Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain (R01 Clinical Trial Not Allowed)
Fondation Maladies Rares Appel à candidatures 2026 ? Bourse de Master 2 ? « Innovation en Intelligence Artificielle & e-Santé pour les Maladies Rares »
NIH NIMH Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R01 Clinical Trial Optional)
